Planning Pregnancy With Epilepsy: Review Your Medicines

0
0

If you’re planning a pregnancy, a preconception review for epilepsy and pregnancy can help you weigh the risks of your current antiseizure medicine against the risks of seizures returning. The goal is not to stop treatment, but to agree with your specialist on a plan that supports seizure control while reducing avoidable exposure risks.

A review before pregnancy: epilepsy and pregnancy

Arrange a conversation with your neurologist or epilepsy specialist before trying to conceive, if possible. Bring a list of medicines and doses, including supplements, and describe your recent seizure pattern, past medicine changes and any side effects. Your clinician can consider your epilepsy type, which medicines have worked, and whether a different regimen is appropriate for you.

Lamotrigine and levetiracetam have comparatively reassuring pregnancy data; oxcarbazepine also has a favourable profile in the clinical review by Bruna Nucera and colleagues, published in 2022. These are not automatically the right choices for everyone: the medicine needs to control your particular seizures. A lower effective dose and a single medicine are often preferred when suitable, but the specific medicine matters as well as the number prescribed.

Why valproate needs a careful discussion

Valproate is linked to a higher risk of major birth defects and to adverse effects on children’s development after exposure during pregnancy. It should generally be avoided when an effective alternative can control seizures. But for some people, other medicines do not provide adequate seizure control. If valproate is part of your treatment, ask your specialist to explain your options and the risks of changing; do not stop or reduce it on your own.

Switching medicines can take time and may lead to breakthrough seizures. That is one reason a review before conception matters: it gives you and your clinician time to assess alternatives and check whether a proposed plan maintains control before pregnancy.

Seizure control and monitoring matter too

Seizure freedom before pregnancy is a helpful sign, but it cannot guarantee that seizures will remain controlled. Generalized convulsive seizures can cause injury and affect oxygen supply to you and the fetus. Pregnancy can also change the amount of some medicines in the bloodstream. Your specialist may measure a baseline level before pregnancy and use it to guide monitoring and dose decisions during pregnancy. Lamotrigine, levetiracetam and oxcarbazepine levels may fall; plans after birth matter too, as levels can rise again.

If lamotrigine is your medicine, read more about how its levels can shift during pregnancy and after birth. Keep taking your prescribed medicine as directed while you arrange a review.

Folic acid: recommendations differ by region

Start folic acid before conception if you may become pregnant, because early development begins before many people know they are pregnant. The 2024 US guideline from the American Academy of Neurology, American Epilepsy Society and Society for Maternal-Fetal Medicine recommends at least 0.4 mg (400 micrograms) daily before conception and during pregnancy for people with epilepsy taking antiseizure medicine. The guideline does not establish that a higher dose is better.

Advice can differ locally. The American College of Obstetricians and Gynecologists recommends 4 mg daily for people with epilepsy, while UK guidance commonly recommends 5 mg. European recommendations are not necessarily uniform across countries. The material available for Australia does not establish a single national dose recommendation, so ask your local clinician which guideline applies. Confirm the dose with your neurologist or pregnancy-care clinician rather than combining supplements or changing a prescribed dose yourself. For general timing and regional background, see this guide to folic acid before pregnancy.

The reason for discussion is that the best dose for people with epilepsy is uncertain. In a 2025 register-based study, Vegrim and colleagues followed women who had given birth in Denmark, Norway and Sweden; high-dose folic acid prescriptions were associated with a modest increase in cancer diagnoses. The study cannot show that folic acid caused the cancers, and it did not establish a dose-specific risk for people with epilepsy. It is a reason to individualize high-dose decisions, not to stop prescribed folic acid.

Make a plan you can follow

Before your appointment, note your seizure history, medicine doses and questions about folic acid. Ask what changes, blood tests or follow-up may be needed before conception, during pregnancy and after birth. If you become pregnant before your review, contact your epilepsy and pregnancy care team promptly; do not make medication changes without their guidance.